• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3026.0
  • ISIN : INE326A01037
2,110.00 -22 (-1.03%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    2,100.60

  • Today’s High

    2,148.00

  • Open

    2,140.10

  • Perv Close

    2,132.00

  • 52W Low

    1,900.00

  • 52W High

    2,529.50

Key Indicators

  • P/E(TTM)

    14.58

  • Mar.Cap (₹Cr.)

    96,483.10

  • Div & Yield %

    0.85

  • Book Value(₹)

    659.00

  • Debt-Equity Ratio

    -1.03

  • AGM Date

    04-Sep-2026

  • EPS

    144.81

  • P/E Ratio

    14.58

Financials Ratios

  • Debt-Equity Ratio

    0.28

  • Mar.Cap (₹Cr.)

    96,483.10

  • RONW (%)

    14.47

  • ROCE (%)

    15.34

Score Board

  • Equity (₹ in Cr.)

    91.45

  • BV (₹)

    659.00

  • Sales( ₹ in Cr.)

    19,512.66

  • NP (in Cr.)

    5,774.01

  • NP Var(%)

    44.0

  • Div%

    900.0

  • CPS (₹)

    141.70

  • EPS (₹)

    126.30

  • Traded Value (₹ in Lakhs)

    96,528.82

  • 52 Week High

    2,529.50

  • 52 Week Low

    1,900.00

  • Price BSE

    2111.0

  • Price NSE

    2,110.00

  • Market Capital( in Cr.)

    96,528.82

  • P/C Ratio

    14.90

  • P/E Ratio

    16.70

  • Price Vs.BV

    126.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 19,512.66 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 19,512.66 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93
Other Income 1,346.44 253.39 115.51 210.02 216.99 129.09
Stock Adjustments -4.66 38.35 15.93 -120.79 242.38 81.86
Total Income 20,854.44 17,259.24 14,797.94 11,348.06 12,231.04 11,266.88
EXPENDITURE :            
Raw Materials 4,870.68 4,963.57 5,041.16 4,676.90 4,709.64 4,264.17
Power and Fuel Cost 385.66 414.63 444.41 447.42 418.45 389.54
Employee Cost 2,544.88 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86
Other Manufacturing Expenses 1,591.55 1,268.19 1,182.52 1,155.60 1,209.09 1,135.79
Selling and Administration Expenses 2,745.98 2,352.64 2,264.54 1,797.13 1,573.22 1,355.01
Miscellaneous Expenses 192.79 378.83 204.01 162.95 1,976.35 253.36
Employee Benefit Expenses 2,544.88 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 12,331.54 11,689.93 11,232.15 10,174.14 11,804.91 9,093.73
Operating Profit 8,522.90 5,569.31 3,565.79 1,173.92 426.13 2,173.15
Interest 121.47 84.50 56.35 98.44 73.47 40.62
Gross Profit 8,401.43 5,484.81 3,509.44 1,075.48 352.66 2,132.53
Depreciation 707.18 647.69 724.75 548.34 514.19 502.83
Profit Before Tax 7,694.25 4,837.12 2,784.69 527.14 -161.53 1,629.70
Current Tax 1,351.29 857.12 484.05 95.89 57.80 362.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -23.60 7.04 -25.45 6.04 -30.63 8.23
Reported Net Profit 6,366.56 3,972.96 2,326.09 425.21 -188.70 1,258.62
Extraordinary Items 592.55 -27.20 23.78 14.42 30.64 41.61
Adjusted Net Profit 5,774.01 4,000.16 2,302.31 410.79 -219.34 1,217.01
Adjustment below Net Profit 4.02 -4.11 -8.79 -1.39 2.42 -7.89
P & L Balance brought forward 20,913.45 17,333.97 15,274.71 15,032.74 15,514.10 14,535.25
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 569.93 389.37 258.04 181.85 295.08 271.88
P & L Balance carried down 26,714.10 20,913.45 17,333.97 15,274.71 15,032.74 15,514.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 900.00 600.00 400.00 200.00 200.00 325.00
Dividend Per Share(Rs) 18.00 12.00 8.00 4.00 4.00 6.50
Earnings Per Share-Unit Curr 139.25 87.01 51.04 9.35 -4.15 27.74
Earnings Per Share(Adj)-Unit Curr 139.25 87.01 51.04 9.35 -4.15 27.74
Book Value 659.09 531.72 452.12 404.66 399.34 409.20
Book Value(Adj)-Unit Curr 659.09 531.72 452.12 404.66 399.34 409.20

Shareholding Pattern

  • Promoter Group

    46.85%

  • Public Share Holding

    53.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,286,394 1,286,394.00 1,286,394 1,286,394
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,286,394 0.28 1,286,394 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 207,194,390 45.31 207,194,390 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,730,900 1.25 5,730,900 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,000 0.00 1,000 1
Others 0 0.00 0 0
Sub Total 212,926,290 46.57 212,926,290 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 9,811 0.00 9,811 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 219,707 0.05 218,307 8
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 102,516,591 22.42 102,516,591 890
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 31,700,411 6.93 31,700,411 31
Mutual Funds / UTI 67,844,799 14.84 67,842,199 39
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12,927,040 2.83 12,927,040 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 215,218,359 47.07 215,214,359 999
2] Non Institution
Bodies Corporate 1,564,153 0.34 1,559,353 1,153
Clearing Members 51,740 0.01 51,740 52
Directors of their Relatives 2,000 0.00 2,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 5,000 0.00 5,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,513,933 0.33 1,513,533 9,099
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 540,484 0.12 540,484 4,172
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 618,470 0.14 618,470 4
Individuals holding nominal share capital up to Rs. 1 lakh 22,514,459 4.92 22,097,628 284,635
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 122,622 0.03 122,622 20
Others 781,051 0.17 779,651 3
Sub Total 27,801,493 6.08 27,378,062 299,272
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 457,232,536 100.00 456,805,105 300,283

Company Background

Lupin LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lupin Ltd
  • BSE Code : 3026.0
  • ISIN : INE326A01037

  • Incorporation Year

    1983

  • Registered Office

    Kalpataru Inspire 3rd Floor
    Off Western Exp HW Santacruz-E, Mumbai,
    Maharashtra-400055

  • Telephone

    91-22-6640 2323

  • FAX

    91-22-6640 8131

  • Chairman

    M D Gupta

  • Managing Director

  • Company Secretary

    Amit Kumar Gupta.

  • Auditor

    B S R & Co LLP/Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Lupin Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lupin 2,111.00 20,452.53 19,512.66 13.88 27.47
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77